CCES – The Canadian Centre for Ethics in Sport announced on the 12th of October that David Troueung, a powerlifting athlete, got a four-year sanction for the violation of an anti-doping rule. Ephedrine is a prohibited stimulant and it was revealed in the sample of the athlete’s urine, collected during the in-competition doping control on the 21st of July.
Ephedrine is classified as a “specified substance” on the Prohibited List and its presence is considered an adverse analytical finding if its urinary concentration exceeds 100 mL/mcg.
The sanction for an anti-doping rule violation involving a specified substance may be increased under the rules of the Canadian CADP – Anti-Doping Program, in case the CCES determines that the athlete had an intention. In the case of David Troueung, the CCES made an assessment of the circumstances and offered a four-year period of ineligibility.
Mr. Troeung accepted the offered sanction in response to the CCES’s notification of the adverse analytical finding. The sanction will last till August 18, 2022. The Toronto athlete has no right to participate in any capacity with any sports signatory to the CADP, as well as training with teammates during his sanction period.
The copy of the CCES’s file outcome summary, according to the rule 7.10 of the CADP can be found at www.cces.ca/sanctionreg.